Corebridge Financial’s ADC Therapeutics ADCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-39,838
Closed -$56.2K 47
2025
Q1
$56.2K Sell
39,838
-592
-1% -$835 ﹤0.01% 2693
2024
Q4
$80.5K Sell
40,430
-3,051
-7% -$6.07K ﹤0.01% 2657
2024
Q3
$137K Buy
43,481
+5,815
+15% +$18.3K ﹤0.01% 2438
2024
Q2
$119K Buy
+37,666
New +$119K ﹤0.01% 2493